LUTZ, Fla., Aug. 21, 2012 (GLOBE NEWSWIRE) -- CytoDyn Inc. (the “Company”) (OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, and other antibody applications, announced today that it will conduct a management update conference call at 1:00pm ET on Thursday, August 23rd.
